March 28 (Reuters) - CervoMed Inc CRVO.O :
* CERVOMED ANNOUNCES UP TO $149.4 MILLION PRIVATE PLACEMENT
FINANCING JOINED BY LEADING HEALTHCARE INVESTORS
* CERVOMED INC: PRO FORMA CASH AND CASH EQUIVALENTS FROM
UPFRONT
PROCEEDS EXPECTED TO PROVIDE RUNWAY THROUGH END OF 2025
* CERVOMED INC: INTENDS TO USE NET PROCEEDS FROM PROPOSED
FINANCING TO FUND RESEARCH & DEVELOPMENT OF ITS CLINICAL-STAGE
PRODUCT CANDIDATE, NEFLAMAPIMOD
Source text for Eikon: ID:nGNX2NX3zQ
Further company coverage: CRVO.O
((Reuters.Briefs@thomsonreuters.com;))